| Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma DS Mohan, MA Samuels, MA Selim, AD Shalodi, RJ Ellis, JR Samuels, ... Gynecologic oncology 70 (2), 165-171, 1998 | 262 | 1998 |
| A randomized, double-blind, placebo-controlled trial of a β-hydroxyl β-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122) L Berk, J James, A Schwartz, E Hug, A Mahadevan, M Samuels, ... Supportive Care in Cancer 16, 1179-1188, 2008 | 142 | 2008 |
| American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for image-guided radiation therapy (IGRT) L Potters, LE Gaspar, B Kavanagh, JM Galvin, AC Hartford, JM Hevezi, ... International journal of radiation oncology, biology, physics 76 (2), 319-325, 2010 | 99 | 2010 |
| Prostate cancer and prostate bed SPECT imaging with ProstaScint®: Semiquantitative correlation with prostatic biopsy results DB Sodee, RJ Ellis, MA Samuels, JP Spirnak, WF Poole, C Riester, ... The Prostate 37 (3), 140-148, 1998 | 78 | 1998 |
| A Phase II Study of Induction Chemotherapy Followed by Thoracic Radiotherapy and Erlotinib in Poor-Risk Stage III Non–Small-Cell Lung Cancer: Results of CALGB 30605 (Alliance … R Lilenbaum, M Samuels, X Wang, FM Kong, PA Jänne, G Masters, ... Journal of Thoracic Oncology 10 (1), 143-147, 2015 | 66 | 2015 |
| Physician attitudes and practices related to voluntary error and near-miss reporting KS Smith, KM Harris, L Potters, R Sharma, S Mutic, HA Gay, J Wright, ... Journal of oncology practice 10 (5), e350-e357, 2014 | 58 | 2014 |
| Transoral robotic surgery for oropharyngeal squamous cell carcinoma in the era of human papillomavirus O Mahmoud, K Sung, FJ Civantos, GR Thomas, MA Samuels Head & neck 40 (4), 710-721, 2018 | 52 | 2018 |
| Feasibility of adaptive MR-guided stereotactic body radiotherapy (SBRT) of lung tumors KR Padgett, GN Simpson, R Llorente, MA Samuels, N Dogan Cureus 10 (4), 2018 | 36 | 2018 |
| Head and neck second primary cancer rates in the human papillomavirus era: A population‐based analysis DA Diaz, IM Reis, DT Weed, N Elsayyad, M Samuels, MC Abramowitz Head & neck 38 (S1), E873-E883, 2016 | 34 | 2016 |
| Stereotactic body radiotherapy in patients with stage I non–small-cell lung cancer aged 75 years and older: retrospective results from a multicenter consortium MA Samuels, S Kandula, T Koru-Sengul, JA Bogart, JK Salama, ... Clinical lung cancer 14 (4), 446-451, 2013 | 34 | 2013 |
| Feasibility and acute toxicities of radioimmunoguided prostate brachytherapy RJ Ellis, DB Sodee, JP Spirnak, KH Dinchman, AW O’Leary, MA Samuels, ... International Journal of Radiation Oncology* Biology* Physics 48 (3), 683-687, 2000 | 34 | 2000 |
| Influence of air inhomogeneities in radiosurgical beams AK Rustgi, MA Samuels, SN Rustgi Medical Dosimetry 22 (2), 95-100, 1997 | 30 | 1997 |
| Ethical surgical triage of patients with head and neck cancer during the COVID‐19 pandemic FJ Civantos, JM Leibowitz, DJ Arnold, VC Stubbs, JH Gross, GR Thomas, ... Head & neck 42 (7), 1423-1447, 2020 | 29 | 2020 |
| Prospective pilot study comparing the need for adaptive radiotherapy in unresected bulky disease and in postoperative patients with head and neck cancer O Mahmoud, IM Reis, MM Samuels, N Elsayyad, E Bossart, J Both, ... Technology in cancer research & treatment 16 (6), 1014-1021, 2017 | 29 | 2017 |
| Id1 delays senescence of primary human melanocytes SD Cummings, B Ryu, MA Samuels, X Yu, AK Meeker, MA Healey, ... Molecular Carcinogenesis: Published in cooperation with the University of …, 2008 | 27 | 2008 |
| Adjuvant therapies utilization pattern and survival outcomes in high-grade head and neck soft tissue sarcoma; a population based study O Mahmoud, R Beck, E Kalyoussef, RC Park, S Baredes, S Kim, ... Oral oncology 66, 28-37, 2017 | 22 | 2017 |
| Disparities in adherence to head and neck cancer follow‐up guidelines HK Perlow, SJ Ramey, V Cassidy, D Kwon, B Farnia, E Nicolli, ... The Laryngoscope 129 (10), 2303-2308, 2019 | 21 | 2019 |
| Safety, clinical activity and pharmacological biomarker evaluation of the DNA-dependent protein kinase (DNA-PK) inhibitor M3814: results from two phase I trials M Mau-Sorensen, M van Bussel, M Kuipers, DL Nielsen, HM Verheul, ... Annals of Oncology 29, viii654, 2018 | 20 | 2018 |
| A phase Ia/Ib trial of the DNA-PK inhibitor M3814 in combination with radiotherapy (RT) in patients (pts) with advanced solid tumors: Dose-escalation results. B Van Triest, L Damstrup, J Falkenius, V Budach, E Troost, M Samuels, ... Journal of Clinical Oncology 36 (15_suppl), 2518-2518, 2018 | 19 | 2018 |
| Combined modality therapy for limited-disease small cell lung cancer L Raez, M Samuels, R Lilenbaum Current treatment options in oncology 6, 69-74, 2005 | 17 | 2005 |
